Isabel Krsnik

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Miguel Á. Sanz, Pau Montesinos, Chelo Rayón et al. · Blood · 2010 · 335 citations · Full text

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

Bruno Paiva, Noemí Puig, María‐Teresa Cedena et al. · Journal of Clinical Oncology · 2019 · 261 citations · Full text

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma

Laura Rosiñol, Albert Oriol, Rafael Ríos et al. · Blood · 2019 · 207 citations · Full text

Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults

Rosa M. Gonzalo‐Daganzo, C Regidor, Trinidad Martín-Donaire et al. · Cytotherapy · 2009 · 153 citations

Regenerative Medicine, Cell Therapy, Transplantation +13

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Pau Montesinos, Chelo Rayón, Edo Vellenga et al. · Blood · 2010 · 135 citations · Full text